 | • レポートコード：MRC2305C063 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、222ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に7,526.26百万ドルであった世界の止血剤＆組織用シーラント市場規模が、2022年には8,266.77百万ドルに成長し、その後年平均10.01％拡大して2027年には13,344.88百万ドルに達すると予測しています。本調査資料では、止血剤＆組織用シーラントの世界市場について総合的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別（止血剤、組織用シーラント）分析、用途別（心臓血管、一般手術、神経科、整形外科、再建手術）分析、エンドユーザー別（外来手術センター、病院、専門クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの内容をまとめました。なお、本書内の企業情報には、3M、Advanced Medical Solutions Group、B. Braun、Baxter International、C. R. Bard、Cardinal Health、Cohera Medical、Cryolife、CSL Behring、Haemacure、HyperBranch Medical Technology、Integra LifeSciences、Johnson & Johnson、NeoMendなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の止血剤＆組織用シーラント市場規模：製品タイプ別 - 止血剤の市場規模 - 組織用シーラントの市場規模 ・世界の止血剤＆組織用シーラント市場規模：用途別 - 心臓血管における市場規模 - 一般手術における市場規模 - 神経科における市場規模 - 整形外科における市場規模 - 再建手術における市場規模 ・世界の止血剤＆組織用シーラント市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 病院における市場規模 - 専門クリニックにおける市場規模 ・世界の止血剤＆組織用シーラント市場規模：地域別 - 南北アメリカの止血剤＆組織用シーラント市場規模 アメリカの止血剤＆組織用シーラント市場規模 カナダの止血剤＆組織用シーラント市場規模 ブラジルの止血剤＆組織用シーラント市場規模 ... - アジア太平洋の止血剤＆組織用シーラント市場規模 日本の止血剤＆組織用シーラント市場規模 中国の止血剤＆組織用シーラント市場規模 インドの止血剤＆組織用シーラント市場規模 韓国の止血剤＆組織用シーラント市場規模 台湾の止血剤＆組織用シーラント市場規模 ... - ヨーロッパ/中東/アフリカの止血剤＆組織用シーラント市場規模 イギリスの止血剤＆組織用シーラント市場規模 ドイツの止血剤＆組織用シーラント市場規模 フランスの止血剤＆組織用シーラント市場規模 ロシアの止血剤＆組織用シーラント市場規模 ... - その他地域の止血剤＆組織用シーラント市場規模 ・競争状況 ・企業情報 |
The Global Hemostats & Tissue Sealants Market size was estimated at USD 7,526.26 million in 2021 and expected to reach USD 8,266.77 million in 2022, and is projected to grow at a CAGR 10.01% to reach USD 13,344.88 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Hemostats & Tissue Sealants to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Hemostats and Tissue sealants. The Hemostats is further studied across Active Hemostats, Flowable Hemostats, and Mechanical Hemostats. The Tissue sealants is further studied across Fibrin Sealants and Synthetic Sealants.
Based on Application, the market was studied across Cardiovascular, General Surgeries, Neurological, Orthopedic, Reconstructive Surgeries, Surgical Repair, Trauma Cases, and Urological.
Based on End User, the market was studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hemostats & Tissue Sealants market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hemostats & Tissue Sealants Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hemostats & Tissue Sealants Market, including 3M, Advanced Medical Solutions Group, B. Braun, Baxter International, C. R. Bard, Cardinal Health, Cohera Medical, Cryolife, CSL Behring, Haemacure, HyperBranch Medical Technology, Integra LifeSciences, Johnson & Johnson, NeoMend, Smith & Nephew, Teijin Pharma, Tissuemed, Vascular Solutions, Vivostat, and Z-Medica.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Hemostats & Tissue Sealants Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hemostats & Tissue Sealants Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hemostats & Tissue Sealants Market?
4. What is the competitive strategic window for opportunities in the Global Hemostats & Tissue Sealants Market?
5. What are the technology trends and regulatory frameworks in the Global Hemostats & Tissue Sealants Market?
6. What is the market share of the leading vendors in the Global Hemostats & Tissue Sealants Market?
7. What modes and strategic moves are considered suitable for entering the Global Hemostats & Tissue Sealants Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in prevalence of chronic diseases that lead to surgical procedures
5.1.1.2. Rise in demand due to higher application in cardiovascular disorders
5.1.1.3. Increasing use for endoscopic procedures
5.1.2. Restraints
5.1.2.1. Low outlining quality
5.1.2.2. High costs of surgical sealants
5.1.2.3. High expenses of surgical procedures
5.1.3. Opportunities
5.1.3.1. Regular launch of new products
5.1.3.2. Increasing applications of sealants in surgeries and other medical applications
5.1.4. Challenges
5.1.4.1. Less access of new adhesive technology and restricted applications
5.2. Cumulative Impact of COVID-19
6. Hemostats & Tissue Sealants Market, by Product Type
6.1. Introduction
6.2. Hemostats
6.3.1. Active Hemostats
6.3.2. Flowable Hemostats
6.3.3. Mechanical Hemostats
6.3. Tissue sealants
6.4.1. Fibrin Sealants
6.4.2. Synthetic Sealants
7. Hemostats & Tissue Sealants Market, by Application
7.1. Introduction
7.2. Cardiovascular
7.3. General Surgeries
7.4. Neurological
7.5. Orthopedic
7.6. Reconstructive Surgeries
7.7. Surgical Repair
7.8. Trauma Cases
7.9. Urological
8. Hemostats & Tissue Sealants Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Clinics
9. Americas Hemostats & Tissue Sealants Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hemostats & Tissue Sealants Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hemostats & Tissue Sealants Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3M
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Advanced Medical Solutions Group
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. B. Braun
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Baxter International
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. C. R. Bard
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cardinal Health
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Cohera Medical
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Cryolife
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. CSL Behring
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Haemacure
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. HyperBranch Medical Technology
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Integra LifeSciences
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Johnson & Johnson
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. NeoMend
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Smith & Nephew
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Teijin Pharma
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Tissuemed
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Vascular Solutions
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Vivostat
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Z-Medica
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing